Is FEV1 associated with quality of life in children with cystic fibrosis? An original article

被引:0
|
作者
Shirzadi, Rohola [1 ]
Navaei, Safoura [1 ]
Modaresi, Mohammadreza [1 ]
Masiha, Farzad [2 ]
机构
[1] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Resp & Sleep Med Res Ctr, Tehran, Iran
[2] Mazandaran Univ Med Sci, Pediat Infect Dis Res Ctr, Sari, Iran
来源
IMMUNOPATHOLOGIA PERSA | 2020年 / 6卷 / 01期
关键词
Pulmonary function; Cystic fibrosis; Spirometry; Quality of life; LUNG-FUNCTION; WALK TEST; STRESS;
D O I
10.15171/ipp.2020.06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Cystic fibrosis (CF) is a serious genetic life-shortening disease. Quality of life (QoL) measurement related to CF children is a relatively new field of research, which includes the patient's perspective in research and clinical practice. Objectives: This study aimed to evaluate the QoL in children with CF and its association with FEV1 (forced expiratory volume in 1 second). Patients and Methods: This cross-sectional study was carried out on 7-14 years old children with CF attending children's medical center from March 2017 to March 2018. Throat swab cultures and spirometry evaluation was performed for all patients. FEV1 was determined and the 6-min walk test (6MWT) was conducted. The patient's psychological status was assessed using the Persian version of pediatric QoL inventory. ANOVA, t test, and chisquare tests were used for data analysis. Results: Seventy-six subjects with the mean age of 10.49 +/- 3.18 years were studied since 59% of them (n=44) were boys. The mean total QoL was 65.34 +/- 17.73. Patients with lower pulmonary function had a lower QoL. There was a significant association between FEV1 and school and emotional functioning (P = 0 .005 and P=0.002, respectively). A significant association was found between SPO2 (peripheral capillary oxygen saturation) reduction after 6MWT and FEV1 decline (P = 0.001). Additionally, a significant association was detected between FEV1 and the distance walked during 6MWT (P = 0.030). Conclusion: Regarding the association between pulmonary function and QoL in CF patients and lower QoL score in our study, the importance of assessing pulmonary function in these patients should not be neglected.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Loss of FEV1 in cystic fibrosis: correlation with HRCT features
    Oikonomou, A
    Manavis, J
    Karagianni, P
    Tsanakas, J
    Wells, AU
    Hansell, DM
    Papadopoulou, F
    Efremidis, SC
    EUROPEAN RADIOLOGY, 2002, 12 (09) : 2229 - 2235
  • [22] Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma
    Lo, David
    Danvers, Lesley
    Roland, Damian
    Richardson, Matthew
    Yang, Yaling
    Beardsmore, Caroline
    Wilson, Andrew
    Gaillard, Erol
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] Loss of FEV1 in cystic fibrosis: correlation with HRCT features
    Anastasia Oikonomou
    John Manavis
    Paraskevi Karagianni
    John Tsanakas
    Athol U. Wells
    David M. Hansell
    Frederica Papadopoulou
    Stavros C. Efremidis
    European Radiology, 2002, 12 : 2229 - 2235
  • [24] Trend of FEV1 in Cystic Fibrosis Patients: A Telehomecare Experience
    Murgia, Fabrizio
    Tagliente, Irene
    Zoppis, Italo
    Mauri, Giancarlo
    Sicurello, Francesco
    Bella, Francesco
    Mercuri, Vanessa
    Santoro, Eugenio
    Castelnuovo, Gianluca
    Bella, Sergio
    2016 IEEE SYMPOSIUM ON COMPUTERS AND COMMUNICATION (ISCC), 2016, : 271 - 273
  • [25] Relationship of Antibiotic Treatment to Recovery after Acute FEV1 Decline in Children with Cystic Fibrosis
    Morgan, Wayne J.
    Wagener, Jeffrey S.
    Pasta, David J.
    Millar, Stefanie J.
    VanDevanter, Donald R.
    Konstan, Michael W.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (06) : 937 - 942
  • [26] Longitudinal association between adolescent mood and FEV1 in cystic fibrosis
    Pham, H.
    Ranganathan, S.
    Jordan, B.
    Vandeleur, M.
    RESPIROLOGY, 2023, 28 : 210 - 210
  • [27] WHAT FACTORS PREDICT FEV1 VARIABILITY IN CYSTIC FIBROSIS PATIENTS?
    Morgan, W. J.
    VanDevanter, D. R.
    Millar, S.
    Pasta, D. J.
    Konstan, M.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 356 - 356
  • [28] Evaluating Use of FEV1 Decline in Diagnosis and Management of Pulmonary Exacerbations in Children with Cystic Fibrosis
    Bouzek, D. C.
    Thompson, M.
    Ren, C. L.
    Sanders, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [29] MEASURING HUFF MANEUVER USE AND FEV1 IN PEDIATRIC CYSTIC FIBROSIS
    Stilphen, S. C.
    Coates, A.
    Corrigan, M.
    Wyatt, C.
    Cairns, A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S299 - S299
  • [30] DETERMINANTS FOR THE EARLY ONSET OF RAPID FEV1 DECLINE IN CYSTIC FIBROSIS
    Szczesniak, R. D.
    Duan, L.
    McPhail, G. L.
    Chini, B.
    Kahill, L.
    Macaluso, M.
    Amin, R. S.
    Clancy, J. P.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 368 - 368